Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Spermatogenesis01:41

Spermatogenesis

124.9K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
124.9K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.6K
Cancer02:18

Cancer

56.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
56.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stereotactic radiosurgery and multimodal integration approaches for germ cell tumor brain relapse.

Journal of neuro-oncology·2026
Same author

Real-World Evidence of Treatment Patterns, Time to Real-World Progression, and Overall Survival of Patients With Testicular Germ Cell Tumors Receiving Palliative Chemotherapy in the United States.

Cancer medicine·2026
Same author

How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

EClinicalMedicine·2026
Same author

Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World Setting.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals.

medRxiv : the preprint server for health sciences·2026
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.6K

Update in germ cell tumours.

Darren R Feldman1

  • 1aGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center bDepartment of Medicine, Weill Medical College of Cornell University, New York, New York, USA.

Current Opinion in Oncology
|April 9, 2015
PubMed
Summary
This summary is machine-generated.

Recent advances in male germ cell tumors (GCTs) include new genetic insights into susceptibility and cisplatin resistance. Surveillance is now preferred for early-stage GCTs, with ongoing research into treatment and survivorship.

More Related Videos

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Teratoma Generation in the Testis Capsule
05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

21.6K
Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency
14:45

Transgenic Rodent Assay for Quantifying Male Germ Cell Mutant Frequency

Published on: August 6, 2014

16.9K
Germ Cell Transplantation and Testis Tissue Xenografting in Mice
10:41

Germ Cell Transplantation and Testis Tissue Xenografting in Mice

Published on: February 6, 2012

30.8K

Area of Science:

  • Oncology
  • Genetics
  • Urology

Background:

  • Male germ cell tumors (GCTs) are the most common solid tumors in young men.
  • Advances in understanding GCT development and treatment have significantly improved outcomes.
  • Continuous research is crucial for addressing remaining challenges in GCT management.

Purpose of the Study:

  • To provide an update on the latest advancements in postpubertal male germ cell tumors (GCTs) over the past 18 months.
  • To highlight new findings in genetic susceptibility, treatment resistance, biomarkers, and clinical management.
  • To discuss ongoing research and future directions in the field of GCT.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Analysis of genetic studies identifying susceptibility loci and pathways involved in cisplatin resistance.
  • Evaluation of clinical outcomes for surveillance and treatment strategies in early-stage GCTs.

Main Results:

  • Identification of single nucleotide polymorphisms and sex-determination genes associated with GCT susceptibility.
  • Elucidation of pathways (PDGFR-PIK3CA-AKT, RAS) involved in cisplatin resistance.
  • Confirmation of excellent outcomes with surveillance for clinical stage I-A nonseminoma and all clinical stage I seminomas.
  • Promising results from dose-dense multidrug regimens, though not yet standard first-line treatment.
  • Identification of circulating tumor cells and microRNAs as potential biomarkers.

Conclusions:

  • Significant research questions persist across all GCT aspects.
  • The field is poised for major discoveries benefiting GCT patients in the coming decade.
  • Continued focus on survivorship issues, including secondary malignancies, is essential.